Free Smoking Cessation Program Now Available in Ireland

Events by 2FIRSTS.ai
Jan.10.2024
Free Smoking Cessation Program Now Available in Ireland
HSE encourages smokers to quit by offering free smoking cessation aids including nicotine replacement therapy.

According to a report by Irish media outlet Limerick Post at a certain time, the Irish Health Service Executive (HSE) is actively encouraging people who quit smoking by offering them free smoking cessation aid packages.

 

A spokesperson from the health service department stated, "Many individuals attempting to quit smoking do not receive the necessary support and treatment methods, such as smoking cessation medications, that provide the greatest chances of success. HSE is here to help you quit smoking by offering free nicotine replacement therapy (NRT) along with other tried and tested support options.

 

The smoking cessation service provided by the HSE is free throughout the year and offers personalized, evidence-based plans tailored to individual needs. It provides a range of support options, which can be combined according to individual preferences, such as:

 

Online personalized quit smoking program tracks its progress; face-to-face and group support from the community; SMS or telephone support available through the toll-free line 1800 201 203; free "Quit Smoking Kit" to aid in preparation for quitting; free provision of nicotine replacement therapy (NRT) with usage guidance; daily advice and support from individuals who have successfully quit smoking or are currently attempting to quit on the "You Can Quit Smoking" Facebook page.

 

The Health and Safety Executive (HSE) recommends several strategies for quitting smoking. These include seeking support from others, including HSE's smoking cessation services, rather than fighting the battle alone. The advice is to focus on maintaining a smoke-free status every day until reaching the milestone of 28 days, as this significantly increases the chances of quitting permanently. Additionally, the use of smoking cessation medications such as Nicotine Replacement Therapy (NRT) is suggested as a safe, effective, and clinically viable method to overcome initial cravings and navigate the first 28 days of quitting.

 

Dr. Paul Kavanagh, the Public Health Medicine Advisor in charge of Ireland's Smoke-Free Plan, has clarified that Nicotine Replacement Therapy (NRT) is both safe and effective. "We know that NRT is very safe and also effective," he said. These medications are strictly regulated by the Irish Health Products Regulatory Authority (HPRA).

 

We are encouraged to see an increasing number of smokers using NRT to help them quit smoking. We have been making efforts to improve the accessibility and availability of this life-saving medication. Smokers, those looking to quit, and the healthcare professionals supporting them can have full trust and confidence in the safety and effectiveness of NRT.

 

Some smokers may be curious about using e-cigarettes or e-liquid to help them quit smoking. We do not have sufficient trust and confidence in the safety and efficacy of e-cigarettes as a means of quitting smoking, so we recommend using NRT to assist them in their quit attempts.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul Ask Court to Pause Antitrust Case Pending Ninth Circuit Review
Altria and Juul are asking a California federal court to pause an antitrust case while they appeal a class certification ruling to the Ninth Circuit. The case alleges that Altria’s 2018 investment in Juul, a $12.8 billion deal for a 35% stake.
May.07 by 2FIRSTS.ai
 BAT Raises Growth Outlook for Smokeless Products as Velo and Vuse Gain Momentum
BAT Raises Growth Outlook for Smokeless Products as Velo and Vuse Gain Momentum
British American Tobacco (BAT) has raised its growth outlook for smokeless products, forecasting “mid-teens” growth for its new category portfolio, including vaping and nicotine pouch products, while global cigarette volumes are expected to decline further.
BAT
Jun.02
  South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea’s cigarette tax debate has resurfaced after the Ministry of Health and Welfare said tobacco price policy needed review, with a poll showing 63% of respondents support higher tobacco taxes.
Regulations
Jun.22
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
2Firsts supports new tobacco and nicotine companies entering the U.S. market with full-chain PMTA compliance services.
Jun.04